Thu, Jul 10, 2014, 12:46 PM EDT - U.S. Markets close in 3 hrs 14 mins

Recent

% | $
Quotes you view appear here for quick access.

Muscle Pharm Corp. Message Board

sean.rico 1 post  |  Last Activity: Nov 9, 2013 9:18 PM Member since: May 30, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • I'm long in both DROP and MSLP and I think this is a great matchup. It seems like Fuse has been doing "okay" with getting their name out there but with the channels of distribution available now with MSLP I think it'll take off even more.

    For those not familiar with Fuse, check out some of the conference calls on the site. I'm not as excited about the supplements as I am the potential to revolutionize medicine. They were able to deliver insulin through a roll-on applicator in trials meaning no needles. Think about how many people are diabetic who wouldn't need to use syringes any longer to deliver meds. The same can be said for meds in pill form that children can't take - if they could take asprin through a dropper it could be revolutionary.

    The sports nutrition angle was just a way to get the product to market to show it worked. I'm in it for the long haul with both. The other thing to mention is that Fuse has a lot more athletes signed such as Andy Murray, David Ortiz and Tiger Woods. If MSLP can leverage those athletes to sponsor their products too it's a win-win for both companies.

    Just trying to keep an open mind but if MSLP went from really nothing upto 10 bucks in a year it's not hard to imagine that Fuse could go from .04 to at least a buck or two in another year. Earnings have been very positive and the last round didn't include revenue from Golf Galaxy (Tiger Woods partnership) or Walgreens distribution.

    Sentiment: Strong Buy

MSLP
12.10+0.07(+0.58%)12:13 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.